Lees Pharmaceutical Holdings Price on May 3, 2023

LPCUFDelisted Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in Lees Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Lees Pharmaceutical stands at 0.0001, as last reported on the 27th of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Lees Pharmaceutical, which you can use to evaluate the volatility of the firm.
  
Lees Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
LPCUF
Based on monthly moving average Lees Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lees Pharmaceutical by adding Lees Pharmaceutical to a well-diversified portfolio.

Lees Pharmaceutical Valuation on May 3, 2023

It is possible to determine the worth of Lees Pharmaceutical on a given historical date. On May 3, 2023 Lees was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lees Pharmaceutical pink sheet. Still, in general, we apply an absolute valuation method to find Lees Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lees Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lees Pharmaceutical's related companies.
 Open High Low Close Volume
  0.0001    0.0001    0.0001    0.0001    1.00  
05/03/2023
  0.0001    0.0001    0.0001    0.0001    1.00  
  0.0001    0.0001    0.0001    0.0001    1.00  
Backtest Lees Pharmaceutical  |  Lees Pharmaceutical History  |  Lees Pharmaceutical Valuation   PreviousNext  
Open Value
1.0E-4
1.0E-4
Closing Value
0.00
Upside

Lees Pharmaceutical Trading Date Momentum on May 3, 2023

On May 04 2023 Lees Pharmaceutical Holdings was traded for  0.0001  at the closing time. The highest daily price throughout the period was 0.0001  and the lowest price was  0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on 05/04/2023 did not cause price change. The trading delta at closing time to current closing price is 0.00% .

Lees Pharmaceutical Fundamentals Correlations and Trends

By evaluating Lees Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lees Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lees financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Lees Pharmaceutical Pink Sheet history

Lees Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lees is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lees Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lees Pharmaceutical stock prices may prove useful in developing a viable investing in Lees Pharmaceutical
Lees Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the Peoples Republic of China. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong. Lees Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1182 people.

Lees Pharmaceutical Pink Sheet Technical Analysis

Lees Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Lees Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lees Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Lees Pharmaceutical Period Price Range

Low
December 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Lees Pharmaceutical Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Lees Pharmaceutical December 27, 2024 Market Strength

Market strength indicators help investors to evaluate how Lees Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lees Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Lees Pharmaceutical pink sheet market strength indicators, traders can identify Lees Pharmaceutical Holdings entry and exit signals to maximize returns
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Lees Pink Sheet

If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk